Revance Therapeutics, Inc. reports

Company location: Nashville, TN
Fiscal year end: 31 December

Revance Therapeutics, Inc. has filed 947 SEC EDGAR filings since 23 Dec 2009

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 26-50 of 946 matching filings.

Per page

Current page

4

Filing date: 06 Feb 2025
Reporting date: 04 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 06 Feb 2025
Reporting date: 04 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 06 Feb 2025
Reporting date: 04 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 06 Feb 2025
Reporting date: 04 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 06 Feb 2025
Reporting date: 04 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 06 Feb 2025
Reporting date: 04 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 06 Feb 2025
Reporting date: 04 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 06 Feb 2025
Reporting date: 04 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 06 Feb 2025
Reporting date: 04 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

25-NSE File 001-36297

25-NSE filing

Filing date: 06 Feb 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36297

8-K

Filing date: 06 Feb 2025
Reporting date: 06 Feb 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

Filing date: 05 Feb 2025
Reporting date: 03 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 05 Feb 2025
Reporting date: 03 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 05 Feb 2025
Reporting date: 03 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 14D9/A File 005-88023

SC 14D9/A

Filing date: 05 Feb 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC TO-T/A File 005-88023

SC TO-T/A

Filing date: 05 Feb 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC TO-T/A File 005-88023

SC TO-T/A

Filing date: 31 Jan 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 14D9/A File 005-88023

SC 14D9/A

Filing date: 31 Jan 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13D/A File 005-88023

SCHEDULE 13D/A filing

Filing date: 30 Jan 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 14D9/A File 005-88023

SC 14D9/A

Filing date: 21 Jan 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC TO-T/A File 005-88023

SC TO-T/A

Filing date: 21 Jan 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36297

FORM 8-K

Filing date: 21 Jan 2025
Reporting date: 17 Jan 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 14D9/A File 005-88023

SC 14D9/A

Filing date: 17 Jan 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 14D9/A File 005-88023

SC 14D9/A

Filing date: 13 Jan 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC TO-T/A File 005-88023

SC TO-T/A

Filing date: 13 Jan 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing